These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14577653)

  • 1. Aldose reductase: a novel target for cardioprotective interventions.
    Ramasamy R
    Curr Drug Targets; 2003 Nov; 4(8):625-32. PubMed ID: 14577653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central role for aldose reductase pathway in myocardial ischemic injury.
    Hwang YC; Kaneko M; Bakr S; Liao H; Lu Y; Lewis ER; Yan S; Ii S; Itakura M; Rui L; Skopicki H; Homma S; Schmidt AM; Oates PJ; Szabolcs M; Ramasamy R
    FASEB J; 2004 Aug; 18(11):1192-9. PubMed ID: 15284219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
    Ramasamy R; Oates PJ; Schaefer S
    Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase: a key player in myocardial ischemic injury.
    Kaneko M; Ramasamy R
    Exerc Sport Sci Rev; 2004 Jan; 32(1):19-23. PubMed ID: 14748545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase activation is a key component of myocardial response to ischemia.
    Hwang YC; Sato S; Tsai JY; Yan S; Bakr S; Zhang H; Oates PJ; Ramasamy R
    FASEB J; 2002 Feb; 16(2):243-5. PubMed ID: 11772943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
    Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
    FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion.
    Ramasamy R; Trueblood N; Schaefer S
    Am J Physiol; 1998 Jul; 275(1):H195-203. PubMed ID: 9688914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat.
    Ramasamy R; Liu H; Oates PJ; Schaefer S
    Cardiovasc Res; 1999 Apr; 42(1):130-9. PubMed ID: 10435004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium.
    Hwang YC; Bakr S; Ellery CA; Oates PJ; Ramasamy R
    FASEB J; 2003 Dec; 17(15):2331-3. PubMed ID: 14525943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury.
    Ananthakrishnan R; Li Q; Gomes T; Schmidt AM; Ramasamy R
    Exp Gerontol; 2011 Sep; 46(9):762-7. PubMed ID: 21600277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
    Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
    Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase inhibition: emerging drug target for the treatment of cardiovascular complications.
    Reddy AB; Ramana KV
    Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):25-32. PubMed ID: 19886861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.
    Kaneko M; Bucciarelli L; Hwang YC; Lee L; Yan SF; Schmidt AM; Ramasamy R
    Ann N Y Acad Sci; 2005 Jun; 1043():702-9. PubMed ID: 16037296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts.
    Trueblood N; Ramasamy R
    Am J Physiol; 1998 Jul; 275(1):H75-83. PubMed ID: 9688898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.
    Balestri F; Quattrini L; Coviello V; Sartini S; Da Settimo F; Cappiello M; Moschini R; Del Corso A; Mura U; La Motta C
    Cell Chem Biol; 2018 Nov; 25(11):1414-1418.e3. PubMed ID: 30122369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.
    Zughaib ME; Sun JZ; Bolli R
    Basic Res Cardiol; 1993; 88 Suppl 1():155-67. PubMed ID: 8357331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ischaemic activity of an antioxidant aldose reductase inhibitor on diabetic and non-diabetic rat hearts.
    Calderone V; Testai L; Martelli A; La Motta C; Sartini S; Da Settimo F; Breschi MC
    J Pharm Pharmacol; 2010 Jan; 62(1):107-13. PubMed ID: 20723006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase.
    Nencetti S; La Motta C; Rossello A; Sartini S; Nuti E; Ciccone L; Orlandini E
    Bioorg Med Chem; 2017 Jun; 25(12):3068-3076. PubMed ID: 28392277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning.
    Shinmura K; Bolli R; Liu SQ; Tang XL; Kodani E; Xuan YT; Srivastava S; Bhatnagar A
    Circ Res; 2002 Aug; 91(3):240-6. PubMed ID: 12169650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.